Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
Product Classification
Formulation Information
CREAM
**Dosage and administration:** A thin film of **DIPROSONE** Cream/Ointment should be applied to cover completely the affected area twice daily, in the morning and at night. For some patients adequate maintenance therapy may be achieved with less frequent application. In some cases of moderate to severe psoriasis or atopic dermatitis, once-a-day application may suffice.
TOPICAL
Medical Information
**Indications and usage: DIPROSONE** Cream/Ointment is indicated for the relief of the inflammatory manifestations of corticosteroid-responsive dermatoses such as: psoriasis, contact dermatitis (dermatitis venenata), atopic dermatitis (infantile eczema, allergic dermatitis), neurodermatitis (lichen simplex chronicus), lichen planus, eczema (including nummular eczema, hand eczema, eczematous dermatitis), intertrigo, dyshidrosis (pompholyx), seborrheic dermatitis, exfoliative dermatitis, solar dermatitis, stasis dermatitis and anogenital and senile pruritus.
**Contraindications: DIPROSONE** Cream/Ointment is contraindicated in those patients with a history of sensitivity to betamethasone dipropionate, other corticosteroids or to any of the components in these preparations.
D07AC01
betamethasone
Manufacturer Information
ORGANON SINGAPORE PTE. LTD.
PT Organon Pharma Indonesia Tbk
Active Ingredients
Documents
Package Inserts
Diprosone Cream PI.pdf
Approved: February 23, 2023